OpenAI’s cofounders once asked Elon Musk, who helped create and fund the company, an important question: If he were to control OpenAI, what would happen to the company on his death? Musk responded that he hadn’t thought about it much and that he might pass it on to his children.
OpenAI’s cofounders once asked Elon Musk, who helped create and fund the company, an important question: If he were to control OpenAI, what would happen to the company on his death? Musk responded that he hadn’t thought about it much and that he might pass it on to his children.
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related conditions, today reported financial results for the first quarter ended March 31, 2026, along with recent business updates and anti...
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related conditions, today reported financial results for the first quarter ended March 31, 2026, along with recent business updates and anticipated milestones.
The case for owning cybersecurity stocks in the age of artificial intelligence just got stronger after new evidence showed that hackers are using AI to accelerate more sophisticated attacks. In a report this week, the Google Threat Intelligence Group (GTIG) found that, for the first time, a threat actor used an AI-developed zero-day exploit designed to circumvent two-factor authentication. Zero-da...
The case for owning cybersecurity stocks in the age of artificial intelligence just got stronger after new evidence showed that hackers are using AI to accelerate more sophisticated attacks. In a report this week, the Google Threat Intelligence Group (GTIG) found that, for the first time, a threat actor used an AI-developed zero-day exploit designed to circumvent two-factor authentication. Zero-day is a cyber industry term referring to a security flaw that goes undiscovered by those who can fix it, making the vulnerability an even more threatening risk. Google researchers said this is an example of adversaries increasingly leveraging AI to automate vulnerabilities, phishing campaigns, and malware development. This heightened threat environment is bullish for AI-native cybersecurity companies like Club holdings CrowdStrike and Palo Alto Networks because it reinforces the idea that cyber spending is mission-critical as companies need to partner with platform providers capable of detecting and responding to threats in real time. It strengthens our investment case for CrowdStrike, which has positioned its Falcon platform and Charlotte AI offerings around autonomous threat detection and response. Palo Alto has also emphasized its AI-driven platform strategy and intelligence capabilities. The Club has long owned buy-equivalent, 1-rated CrowdStrike, which we like the best in the group. We have Palo Alto as a 3 rating , meaning we're looking to sell it into strength. Jim Cramer decided we only need one cybersecurity name in the portfolio and wants to make room for other opportunities in other sectors. Both cybersecurity companies were higher Tuesday, after CrowdStrike and Palo Alto returned 44% and 38%, respectively, over the past month. That's a major positive reversal from the pressure they were under earlier this year in the broader sell-off in software stocks amid worries of AI disruption. We never felt that was right. CRWD PANW YTD mountain CrowdStrike and Palo Alto Ne...
Man in 40s who was barricaded in property ‘presented weapon’ before officers fired, say Bedfordshire police A man has been shot dead by police in Bedford after he barricaded himself inside a property overnight. Officers were called to reports of vehicles being damaged at about 10.40pm on Monday and found a man in his 40s who had blockaded himself inside a home and was making threats, Bedfordshire ...
Man in 40s who was barricaded in property ‘presented weapon’ before officers fired, say Bedfordshire police A man has been shot dead by police in Bedford after he barricaded himself inside a property overnight. Officers were called to reports of vehicles being damaged at about 10.40pm on Monday and found a man in his 40s who had blockaded himself inside a home and was making threats, Bedfordshire police said. Continue reading...
When Warren Buffett officially retired from day-to-day leadership at Berkshire Hathaway in late 2025, it marked the end of an era. Buffett transformed Berkshire into a trillion-dollar conglomerate with stakes in some of the world’s most dominant businesses. And it was clear from the start that filling his shoes would not be easy. In January, ... Greg Abel Just Quietly Dumped a Major Berkshire Hold...
When Warren Buffett officially retired from day-to-day leadership at Berkshire Hathaway in late 2025, it marked the end of an era. Buffett transformed Berkshire into a trillion-dollar conglomerate with stakes in some of the world’s most dominant businesses. And it was clear from the start that filling his shoes would not be easy. In January, ... Greg Abel Just Quietly Dumped a Major Berkshire Holding. Here Is What Buffett’s Successor Is Buying Instead.
JHVEPhoto/iStock Editorial via Getty Images Listen below or on the go on Apple Podcasts and Spotify Board call’s GME’s $56B takeover proposal neither attractive nor credible . (0:15) Energy prices push April core and headline CPI higher . (0:50) Quantum Computing reports nearly 9,000% revenue growth . (1:49) This is an abridged transcript of the podcast: Our top story so far, the bid has been reje...
JHVEPhoto/iStock Editorial via Getty Images Listen below or on the go on Apple Podcasts and Spotify Board call’s GME’s $56B takeover proposal neither attractive nor credible . (0:15) Energy prices push April core and headline CPI higher . (0:50) Quantum Computing reports nearly 9,000% revenue growth . (1:49) This is an abridged transcript of the podcast: Our top story so far, the bid has been rejected. The question now: does this move toward an auction? eBay ( EBAY ) turned down GameStop’s ( GME ) $56B takeover proposal, calling it “neither credible nor attractive.” In a letter to CEO Ryan Cohen, eBay’s board cited the company’s standalone prospects, uncertainty around GameStop’s financing, the leverage and operational risks of a combined entity, and concerns around governance and executive incentives. The board said it remains confident in eBay’s current management and long-term strategy. GameStop’s offer was valued at roughly $125 per share in cash and stock. Shares of both companies are trading slightly lower. On the economic front, retail inflation accelerated in April as higher energy prices filtered through both headline and core measures. Core CPI rose 0.4% for the month, above the 0.3% consensus and up from 0.2% in March. The annual rate ticked up to 2.8%. Headline CPI increased 0.6% month over month, bringing the annual rate to 3.8%, in line with expectations. Airline fares jumped 2.8% as jet fuel costs climbed, while categories such as household furnishings, personal care and apparel also posted firm gains. Core services excluding housing rose 0.45%, one of the strongest readings of the year. Skyler Weinand of Regan Capital said the inflation surge is energy-driven rather than structural, but still likely keeps the Fed on hold through the summer. He added that rising food and materials input costs could complicate the policy outlook, as those pressures are difficult to offset with interest rates alone. Among active stocks, Quantum Computing ( QUBT ) is ral...
mbbirdy/E+ via Getty Images Mark Zandi, chief economist at Moody’s Analytics, is sounding the alarm on inflation, warning that the current trajectory of rising prices is troubling. “Inflation obviously is high, and the direction of travel feels disconcerting,” Zandi said in an interview with CNBC following the release of the latest inflation report. The breadth of price increases is what concerns ...
mbbirdy/E+ via Getty Images Mark Zandi, chief economist at Moody’s Analytics, is sounding the alarm on inflation, warning that the current trajectory of rising prices is troubling. “Inflation obviously is high, and the direction of travel feels disconcerting,” Zandi said in an interview with CNBC following the release of the latest inflation report. The breadth of price increases is what concerns Zandi most, as inflation is no longer confined to energy costs. Household furniture prices, clothing, and airfares are all climbing, with energy spikes flowing through to grocery prices due to the cost of transporting food from farms and ports to store shelves. “It does feel like the inflationary effects are broadening out and will impact the prices more broadly,” Zandi noted, adding that core goods inflation was also up strongly. Beyond rising energy costs, geopolitical factors and trade policy are adding pressure to an already strained economy. Zandi pointed to the war in Iran and ongoing tariffs as additional drivers of inflation, explaining that these factors are “weighing on economic growth and raising inflation” simultaneously. The Federal Reserve now faces an unenviable position, caught between supporting a weakening economy and combating rising inflation expectations. Higher energy prices and tariffs argue for lower rates to ease consumer burdens, while elevated inflation suggests the opposite approach is needed. Zandi described the central bank as being “kinda stuck in between” these competing pressures. While Zandi expects the Fed to stay on hold for now, a view he says is the widespread expectation, he identified inflation expectations as the key metric to watch. He monitors “breakevens” as his preferred measure, noting they are already on the high side of their historical range. If inflation expectations continue to drift higher and break out further, Zandi warned the Fed may be forced to act. At that point, the central bank will “likely focus on the inflation s...
Earnings Call Insights: STERIS plc (STE) Q4 2026 Management View “Fiscal 2026 was another record year for STERIS with 9% revenue growth, 7% on a constant currency organic basis,” said President, CEO & Director Daniel Carestio, adding that the company delivered “10% adjusted earnings per share growth” despite “the 80 basis points of impact from tariffs on margins.” Carestio highlighted segment mile...
Earnings Call Insights: STERIS plc (STE) Q4 2026 Management View “Fiscal 2026 was another record year for STERIS with 9% revenue growth, 7% on a constant currency organic basis,” said President, CEO & Director Daniel Carestio, adding that the company delivered “10% adjusted earnings per share growth” despite “the 80 basis points of impact from tariffs on margins.” Carestio highlighted segment milestones, including Healthcare reaching “$4 billion in revenue and $1 billion in operating income,” and AST surpassing “over $1 billion in revenue” and “exceeding $500 million in operating profit.” He also cited Healthcare mix and share gains: services grew “12%” and consumables grew “7%… as we continue to pick up share.” Senior VP, CFO & Chief Accounting Officer Karen Burton said, “For the fourth quarter, total as reported revenue grew 7%,” with “Constant currency organic revenue” up “5%… as well as 230 basis points of price,” while noting “Gross margin for the quarter was 44%” and “EBIT margin for the quarter was 24.2% of revenue.” Carestio disclosed capital return and authorization changes: “As you saw in our press release, the Board has approved a new $1 billion buyback authorization,” and “we expect to utilize excess cash to consistently buy back shares in the range of $200 million to $300 million per year.” Outlook “We anticipate as-reported revenue to grow 7% to 8% in fiscal 2027,” Carestio said, and “constant currency organic revenue growth is expected to be 6% to 7% for the total company,” assuming “approximately 200 basis points of price.” Segment growth expectations were laid out as “Healthcare and Life Sciences to grow 6% to 7% constant currency organic and AST to grow 7% to 8%,” with Carestio adding, “We are taking a more conservative approach on our outlook to AST to start the year,” citing customers that “continue to manage inventory levels carefully” and “difficult comparisons in the first half.” Carestio guided profitability and cash generation, stating, “For...
Tom Werner/DigitalVision via Getty Images On May 1st , the FDA approved Veppanu (vepdegestrant), a novel small molecule degrader of the estrogen receptor (ER) to treat ER+/HER2- breast cancer for relapsed patients with ESR1 mutations. This is an important scientific milestone, the first FDA-approved Preteolysis Targeting Chimera (PROTAC). A PROTAC drug is based on Nobel Prize winning science in ub...
Tom Werner/DigitalVision via Getty Images On May 1st , the FDA approved Veppanu (vepdegestrant), a novel small molecule degrader of the estrogen receptor (ER) to treat ER+/HER2- breast cancer for relapsed patients with ESR1 mutations. This is an important scientific milestone, the first FDA-approved Preteolysis Targeting Chimera (PROTAC). A PROTAC drug is based on Nobel Prize winning science in ubiquitin-mediated protein degradation. In short, PROTAC drugs bind a target of interest, tagging it for destruction by this natural pathway. The offending protein is degraded by the ubiquitin-proteasome system resulting in destruction, rather than simple inhibition that is achieved by most small molecule drugs. Arvinas ( ARVN ) together with its partner Pfizer ( PFE ) have deep expertise in the field, with Arvinas' founder Craig Crews a renowned and pioneering research professor at Yale University. I was very interested to research this development, particularly because the ER+/HER2- breast cancer market is objectively large ( $6.75B in 2022 sales ). In the front-line setting, patients diagnosed with ER+/HER2- breast cancer are generally treated with a CDK4/6 kinase inhibitor, such as blockbusters Kisqali, Ibrance, or Verzenio, along with antiestrogen hormone therapy. While this presents most patients with a good prognosis, treatment often continues for years. Over time, relapsed patients frequently present genetic mutations in ER, with 40% seeing ESR1 mutations. Thus, Veppanu has significant commercial prospects in the large second-line market. Potentially, Veppanu could even be expanded into the front-line market on the hypothesis that a PROTAC might bypass resistance mechanisms by degrading the ER rather than simply inhibiting it. Indeed, the company had been attempting just that with VERITAC-3 recruiting to combine Veppanu and Pfizer's Ibrance (palbociclib). Unfortunately, this study will not proceed, with Pfizer pulling support, perhaps due to the looming loss of exclus...
Earnings Call Insights: Netlist (NLST) Q1 2026 Management view “We delivered a strong first quarter performance, achieving record quarterly revenue and a significant improvement in profitability,” said (Co-Founder, President, CEO & Executive Chairman Chuck Hong), attributing the quarter to “robust demand for our memory products and disciplined execution across the business.” (CEO Hong) framed indu...
Earnings Call Insights: Netlist (NLST) Q1 2026 Management view “We delivered a strong first quarter performance, achieving record quarterly revenue and a significant improvement in profitability,” said (Co-Founder, President, CEO & Executive Chairman Chuck Hong), attributing the quarter to “robust demand for our memory products and disciplined execution across the business.” (CEO Hong) framed industry conditions as persistently tight, saying “the memory market remains structurally undersupplied,” and adding that “AI-driven demand continues to accelerate while DRAM capacity remains constrained.” He also said “industry-wide supply constraints are expected to persist until new fabrication capacity comes online later next year, which could delay meaningful relief until 2029.” On products, (CEO Hong) said “our Lightning portfolio of overclock low-latency DDR5 RDIMM and UDIMM solutions continue to ramp,” and that Netlist is “progressing through qualifications with OEMs, particularly in high-frequency trading and high-performance computing space.” He added, “industrial and networking customers with our DDR4-based custom solutions… accounted for a major portion of our revenues this quarter.” On next-generation platforms, (CEO Hong) said “we are advancing CXL NVDIMM and low-power MRDIMM solutions,” and described the CXL offering: “Our CXL NVvault is a CXL Type 3 persistent memory designed to extend memory class storage beyond the CPU socket while preserving low latency and data durability.” (Executive VP, CFO & Corporate Secretary Gail Sasaki) said, “Revenue was $104.9 million,” and added that results reflected “tight memory supply, accelerating demand and rising DRAM prices, which supported both revenue and gross profit margin improvement.” Outlook The company did not provide formal numeric guidance in this transcript; (CFO Sasaki) focused on the current environment, saying results reflect “the strength of the current industry environment.” (CEO Hong) provided market expect...
Google and SpaceX are in talks to build data centers in orbit, pitching space as the future home for AI compute, even as costs today remain far higher than on the ground.
Google and SpaceX are in talks to build data centers in orbit, pitching space as the future home for AI compute, even as costs today remain far higher than on the ground.
Google and SpaceX are in talks to build data centers in orbit, pitching space as the future home for AI compute, even as costs today remain far higher than on the ground.
Google and SpaceX are in talks to build data centers in orbit, pitching space as the future home for AI compute, even as costs today remain far higher than on the ground.